- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Mesalamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Mesalamine size is estimated to be xx million in 2021 from USD 155.9 million in 2020, with a change of XX% between 2020 and 2021. The global Mesalamine market size is expected to grow at a CAGR of 3.1% for the next five years.
Market segmentation
Mesalamine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity ‚â• 97%
Purity ‚â• 98%
Purity ‚â• 99%
Market segment by Application can be divided into
Mesalazine Tablets
Mesalazine Capsules
Others
The key market players for global Mesalamine market are listed below:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Mesalamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine in 2018 and 2019.
Chapter 3, the Mesalamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Mesalamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mesalamine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Purity ‚â• 97%
1.2.3 Purity ‚â• 98%
1.2.4 Purity ‚â• 99%
1.3 Market Analysis by Application
1.3.1 Overview: Global Mesalamine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Global Mesalamine Market Size & Forecast
1.4.1 Global Mesalamine Sales in Value (2016-2026))
1.4.2 Global Mesalamine Sales in Volume (2016-2026)
1.4.3 Global Mesalamine Price by Type (2016-2026) & (USD/Kg)
1.5 Global Mesalamine Production Capacity Analysis
1.5.1 Global Mesalamine Total Production Capacity (2016-2026)
1.5.2 Global Mesalamine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mesalamine Market Drivers
1.6.2 Mesalamine Market Restraints
1.6.3 Mesalamine Trends Analysis
2 Manufacturers Profiles
2.1 Syntese A/S
2.1.1 Syntese A/S Details
2.1.2 Syntese A/S Major Business
2.1.3 Syntese A/S Mesalamine Product and Services
2.1.4 Syntese A/S Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Divis Laboratories
2.2.1 Divis Laboratories Details
2.2.2 Divis Laboratories Major Business
2.2.3 Divis Laboratories Mesalamine Product and Services
2.2.4 Divis Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cambrex Corporation
2.3.1 Cambrex Corporation Details
2.3.2 Cambrex Corporation Major Business
2.3.3 Cambrex Corporation Mesalamine Product and Services
2.3.4 Cambrex Corporation Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Ipca Laboratories
2.4.1 Ipca Laboratories Details
2.4.2 Ipca Laboratories Major Business
2.4.3 Ipca Laboratories Mesalamine Product and Services
2.4.4 Ipca Laboratories Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Hangzhou Brother
2.5.1 Hangzhou Brother Details
2.5.2 Hangzhou Brother Major Business
2.5.3 Hangzhou Brother Mesalamine Product and Services
2.5.4 Hangzhou Brother Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 PharmaZell
2.6.1 PharmaZell Details
2.6.2 PharmaZell Major Business
2.6.3 PharmaZell Mesalamine Product and Services
2.6.4 PharmaZell Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Lianyungang Fengheng Biopharm
2.7.1 Lianyungang Fengheng Biopharm Details
2.7.2 Lianyungang Fengheng Biopharm Major Business
2.7.3 Lianyungang Fengheng Biopharm Mesalamine Product and Services
2.7.4 Lianyungang Fengheng Biopharm Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Lasa Loboratory
2.8.1 Lasa Loboratory Details
2.8.2 Lasa Loboratory Major Business
2.8.3 Lasa Loboratory Mesalamine Product and Services
2.8.4 Lasa Loboratory Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Erregierre SpA
2.9.1 Erregierre SpA Details
2.9.2 Erregierre SpA Major Business
2.9.3 Erregierre SpA Mesalamine Product and Services
2.9.4 Erregierre SpA Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Corden Pharma Bergamo
2.10.1 Corden Pharma Bergamo Details
2.10.2 Corden Pharma Bergamo Major Business
2.10.3 Corden Pharma Bergamo Mesalamine Product and Services
2.10.4 Corden Pharma Bergamo Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 CTX Lifescience
2.11.1 CTX Lifescience Details
2.11.2 CTX Lifescience Major Business
2.11.3 CTX Lifescience Mesalamine Product and Services
2.11.4 CTX Lifescience Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Ishita Active Pharma Ingredients
2.12.1 Ishita Active Pharma Ingredients Details
2.12.2 Ishita Active Pharma Ingredients Major Business
2.12.3 Ishita Active Pharma Ingredients Mesalamine Product and Services
2.12.4 Ishita Active Pharma Ingredients Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 YC Biotech (Jiangsu)
2.13.1 YC Biotech (Jiangsu) Details
2.13.2 YC Biotech (Jiangsu) Major Business
2.13.3 YC Biotech (Jiangsu) Mesalamine Product and Services
2.13.4 YC Biotech (Jiangsu) Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Xinxiang Tianfeng Fine Chemical
2.14.1 Xinxiang Tianfeng Fine Chemical Details
2.14.2 Xinxiang Tianfeng Fine Chemical Major Business
2.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
2.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Mesalamine Sales by Manufacturer
3.1 Global Mesalamine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Mesalamine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Mesalamine
3.4 Market Concentration Rate
3.4.1 Top 3 Mesalamine Manufacturer Market Share
3.4.2 Top 6 Mesalamine Manufacturer Market Share
3.5 Global Mesalamine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Mesalamine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mesalamine Market Size by Region
4.1.1 Global Mesalamine Sales in Volume by Region (2016-2026)
4.1.2 Global Mesalamine Revenue by Region (2016-2026)
4.2 North America Mesalamine Revenue (2016-2026)
4.3 Europe Mesalamine Revenue (2016-2026)
4.4 Asia-Pacific Mesalamine Revenue (2016-2026)
4.5 South America Mesalamine Revenue (2016-2026)
4.6 Middle East and Africa Mesalamine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Mesalamine Sales in Volume by Type (2016-2026)
5.2 Global Mesalamine Revenue by Type (2016-2026)
5.3 Global Mesalamine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Mesalamine Sales in Volume by Application (2016-2026)
6.2 Global Mesalamine Revenue by Application (2016-2026)
6.3 Global Mesalamine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Mesalamine Sales by Type (2016-2026)
7.2 North America Mesalamine Sales by Application (2016-2026)
7.3 North America Mesalamine Market Size by Country
7.3.1 North America Mesalamine Sales in Volume by Country (2016-2026)
7.3.2 North America Mesalamine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Mesalamine Sales by Type (2016-2026)
8.2 Europe Mesalamine Sales by Application (2016-2026)
8.3 Europe Mesalamine Market Size by Country
8.3.1 Europe Mesalamine Sales in Volume by Country (2016-2026)
8.3.2 Europe Mesalamine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Mesalamine Sales by Type (2016-2026)
9.2 Asia-Pacific Mesalamine Sales by Application (2016-2026)
9.3 Asia-Pacific Mesalamine Market Size by Region
9.3.1 Asia-Pacific Mesalamine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Mesalamine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Mesalamine Sales by Type (2016-2026)
10.2 South America Mesalamine Sales by Application (2016-2026)
10.3 South America Mesalamine Market Size by Country
10.3.1 South America Mesalamine Sales in Volume by Country (2016-2026)
10.3.2 South America Mesalamine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mesalamine Sales by Type (2016-2026)
11.2 Middle East & Africa Mesalamine Sales by Application (2016-2026)
11.3 Middle East & Africa Mesalamine Market Size by Country
11.3.1 Middle East & Africa Mesalamine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Mesalamine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Mesalamine Typical Distributors
12.3 Mesalamine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Mesalamine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Mesalamine Revenue by Application, (USD Million), 2021-2026
Table 3. Syntese A/S Basic Information, Manufacturing Base and Competitors
Table 4. Syntese A/S Major Business
Table 5. Syntese A/S Mesalamine Product and Services
Table 6. Syntese A/S Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Divis Laboratories Major Business
Table 9. Divis Laboratories Mesalamine Product and Services
Table 10. Divis Laboratories Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cambrex Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Cambrex Corporation Major Business
Table 13. Cambrex Corporation Mesalamine Product and Services
Table 14. Cambrex Corporation Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Ipca Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Ipca Laboratories Major Business
Table 17. Ipca Laboratories Mesalamine Product and Services
Table 18. Ipca Laboratories Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hangzhou Brother Basic Information, Manufacturing Base and Competitors
Table 20. Hangzhou Brother Major Business
Table 21. Hangzhou Brother Mesalamine Product and Services
Table 22. Hangzhou Brother Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. PharmaZell Basic Information, Manufacturing Base and Competitors
Table 24. PharmaZell Major Business
Table 25. PharmaZell Mesalamine Product and Services
Table 26. PharmaZell Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Lianyungang Fengheng Biopharm Basic Information, Manufacturing Base and Competitors
Table 28. Lianyungang Fengheng Biopharm Major Business
Table 29. Lianyungang Fengheng Biopharm Mesalamine Product and Services
Table 30. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lasa Loboratory Basic Information, Manufacturing Base and Competitors
Table 32. Lasa Loboratory Major Business
Table 33. Lasa Loboratory Mesalamine Product and Services
Table 34. Lasa Loboratory Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Erregierre SpA Basic Information, Manufacturing Base and Competitors
Table 36. Erregierre SpA Major Business
Table 37. Erregierre SpA Mesalamine Product and Services
Table 38. Erregierre SpA Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors
Table 40. Corden Pharma Bergamo Major Business
Table 41. Corden Pharma Bergamo Mesalamine Product and Services
Table 42. Corden Pharma Bergamo Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. CTX Lifescience Basic Information, Manufacturing Base and Competitors
Table 44. CTX Lifescience Major Business
Table 45. CTX Lifescience Mesalamine Product and Services
Table 46. CTX Lifescience Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors
Table 48. Ishita Active Pharma Ingredients Major Business
Table 49. Ishita Active Pharma Ingredients Mesalamine Product and Services
Table 50. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors
Table 52. YC Biotech (Jiangsu) Major Business
Table 53. YC Biotech (Jiangsu) Mesalamine Product and Services
Table 54. YC Biotech (Jiangsu) Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 56. Xinxiang Tianfeng Fine Chemical Major Business
Table 57. Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
Table 58. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Mesalamine Sales by Manufacturer (2019-2021e) & (MT)
Table 60. Global Mesalamine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Mesalamine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Mesalamine Production Capacity by Company, (MT): 2020 VS 2021
Table 63. Head Office and Mesalamine Production Site of Key Manufacturer
Table 64. Mesalamine New Entrant and Capacity Expansion Plans
Table 65. Mesalamine Mergers & Acquisitions in the Past Five Years
Table 66. Global Mesalamine Sales by Region (2016-2021e) & (MT)
Table 67. Global Mesalamine Sales by Region (2021-2026) & (MT)
Table 68. Global Mesalamine Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Mesalamine Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Mesalamine Sales by Type (2016-2021e) & (MT)
Table 71. Global Mesalamine Sales by Type (2021-2026) & (MT)
Table 72. Global Mesalamine Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Mesalamine Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Mesalamine Price by Type (2016-2021e) & (USD/Kg)
Table 75. Global Mesalamine Price by Type (2021-2026) & (USD/Kg)
Table 76. Global Mesalamine Sales by Application (2016-2021e) & (MT)
Table 77. Global Mesalamine Sales by Application (2021-2026) & (MT)
Table 78. Global Mesalamine Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Mesalamine Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Mesalamine Price by Application (2016-2021e) & (USD/Kg)
Table 81. Global Mesalamine Price by Application (2021-2026) & (USD/Kg)
Table 82. North America Mesalamine Sales by Country (2016-2021e) & (MT)
Table 83. North America Mesalamine Sales by Country (2021-2026) & (MT)
Table 84. North America Mesalamine Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Mesalamine Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Mesalamine Sales by Type (2016-2021e) & (MT)
Table 87. North America Mesalamine Sales by Type (2021-2026) & (MT)
Table 88. North America Mesalamine Sales by Application (2016-2021e) & (MT)
Table 89. North America Mesalamine Sales by Application (2021-2026) & (MT)
Table 90. Europe Mesalamine Sales by Country (2016-2021e) & (MT)
Table 91. Europe Mesalamine Sales by Country (2021-2026) & (MT)
Table 92. Europe Mesalamine Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Mesalamine Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Mesalamine Sales by Type (2016-2021e) & (MT)
Table 95. Europe Mesalamine Sales by Type (2021-2026) & (MT)
Table 96. Europe Mesalamine Sales by Application (2016-2021e) & (MT)
Table 97. Europe Mesalamine Sales by Application (2021-2026) & (MT)
Table 98. Asia-Pacific Mesalamine Sales by Region (2016-2021e) & (MT)
Table 99. Asia-Pacific Mesalamine Sales by Region (2021-2026) & (MT)
Table 100. Asia-Pacific Mesalamine Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Mesalamine Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Mesalamine Sales by Type (2016-2021e) & (MT)
Table 103. Asia-Pacific Mesalamine Sales by Type (2021-2026) & (MT)
Table 104. Asia-Pacific Mesalamine Sales by Application (2016-2021e) & (MT)
Table 105. Asia-Pacific Mesalamine Sales by Application (2021-2026) & (MT)
Table 106. South America Mesalamine Sales by Country (2016-2021e) & (MT)
Table 107. South America Mesalamine Sales by Country (2021-2026) & (MT)
Table 108. South America Mesalamine Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Mesalamine Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Mesalamine Sales by Type (2016-2021e) & (MT)
Table 111. South America Mesalamine Sales by Type (2021-2026) & (MT)
Table 112. South America Mesalamine Sales by Application (2016-2021e) & (MT)
Table 113. South America Mesalamine Sales by Application (2021-2026) & (MT)
Table 114. Middle East & Africa Mesalamine Sales by Country (2016-2021e) & (MT)
Table 115. Middle East & Africa Mesalamine Sales by Country (2021-2026) & (MT)
Table 116. Middle East & Africa Mesalamine Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Mesalamine Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Mesalamine Sales by Type (2016-2021e) & (MT)
Table 119. Middle East & Africa Mesalamine Sales by Type (2021-2026) & (MT)
Table 120. Middle East & Africa Mesalamine Sales by Application (2016-2021e) & (MT)
Table 121. Middle East & Africa Mesalamine Sales by Application (2021-2026) & (MT)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Mesalamine Typical Distributors
Table 125. Mesalamine Typical Customers
List of Figures
Figure 1. Mesalamine Picture
Figure 2. Global Mesalamine Sales Market Share by Type in 2020
Figure 3. Purity ‚â• 97%
Figure 4. Purity ‚â• 98%
Figure 5. Purity ‚â• 99%
Figure 6. Global Mesalamine Sales Market Share by Application in 2020
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Global Mesalamine Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Mesalamine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Mesalamine Sales (2016-2026) & (MT)
Figure 13. Global Mesalamine Price by Type (2016-2026) & (USD/Kg)
Figure 14. Global Mesalamine Production Capacity (2016-2026) & (MT)
Figure 15. Global Mesalamine Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Mesalamine Market Drivers
Figure 17. Mesalamine Market Restraints
Figure 18. Mesalamine Market Trends
Figure 19. Global Mesalamine Sales Market Share by Manufacturer in 2020
Figure 20. Global Mesalamine Revenue Market Share by Manufacturer in 2020
Figure 21. Mesalamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Mesalamine Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Mesalamine Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Mesalamine Sales Market Share by Region (2016-2026)
Figure 25. Global Mesalamine Revenue Market Share by Region (2016-2026)
Figure 26. North America Mesalamine Revenue (2016-2026) & (USD Million)
Figure 27. Europe Mesalamine Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Mesalamine Revenue (2016-2026) & (USD Million)
Figure 29. South America Mesalamine Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Mesalamine Revenue (2016-2026) & (USD Million)
Figure 31. Global Mesalamine Sales Market Share by Type (2016-2026)
Figure 32. Global Mesalamine Revenue Market Share by Type (2016-2026)
Figure 33. Global Mesalamine Price by Type (2016-2026) & (USD/Kg)
Figure 34. Global Mesalamine Sales Market Share by Application (2016-2026)
Figure 35. Global Mesalamine Revenue Market Share by Application (2016-2026)
Figure 36. Global Mesalamine Price by Application (2016-2026) & (USD/Kg)
Figure 37. North America Mesalamine Sales Market Share by Type (2016-2026)
Figure 38. North America Mesalamine Sales Market Share by Application (2016-2026)
Figure 39. North America Mesalamine Sales Market Share by Country (2016-2026)
Figure 40. North America Mesalamine Revenue Market Share by Country (2016-2026)
Figure 41. United States Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Mesalamine Sales Market Share by Type (2016-2026)
Figure 45. Europe Mesalamine Sales Market Share by Application (2016-2026)
Figure 46. Europe Mesalamine Sales Market Share by Country (2016-2026)
Figure 47. Europe Mesalamine Revenue Market Share by Country (2016-2026)
Figure 48. Germany Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Mesalamine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Mesalamine Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Mesalamine Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Mesalamine Revenue Market Share by Region (2016-2026)
Figure 57. China Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Mesalamine Sales Market Share by Type (2016-2026)
Figure 64. South America Mesalamine Sales Market Share by Application (2016-2026)
Figure 65. South America Mesalamine Sales Market Share by Country (2016-2026)
Figure 66. South America Mesalamine Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Mesalamine Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Mesalamine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Mesalamine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Mesalamine Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Mesalamine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
